We have demonstrated for the first time a reduction in insulin signaling pathway proteins PI3-K/Akt/mTOR pathway in the brain of STZ treated rats that may be implicated as a dominant factor in neurodegeneration leading to cognitive dysfunction seen in diabetics. This evidence concerns the gene INS and diabetes mellitus.